Unknown

Dataset Information

0

The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.


ABSTRACT: Pathogenic variants in BRCA1 are associated with a greatly increased risk of hereditary breast and ovarian cancer (HBOC). With the increased availability and affordability of genetic testing, many individuals have been identified with BRCA1 variants of uncertain significance (VUSs), which are individually detected in the population too infrequently to ascertain a clinical risk. Functional assays can be used to experimentally assess the effects of these variants. In this study, we used multiplexed DNA repair assays of variants in the BRCA1 carboxyl terminus to functionally characterize 2,271 variants for homology-directed repair function (HDR) and 1,427 variants for cisplatin resistance (CR). We found a high level of consistent results (Pearson's r = 0.74) in the two multiplexed functional assays with non-functional variants located within regions of the BRCA1 protein necessary for its tumor suppression activity. In addition, functional categorizations of variants tested in the multiplex HDR and CR assays correlated with known clinical significance and with other functional assays for BRCA1 (Pearson's r = 0.53 to 0.71). The results of the multiplex HDR and CR assays are useful resources for characterizing large numbers of BRCA1 VUSs.

SUBMITTER: Adamovich AI 

PROVIDER: S-EPMC9069074 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.

Adamovich Aleksandra I AI   Diabate Mariame M   Banerjee Tapahsama T   Nagy Gregory G   Smith Nahum N   Duncan Kathryn K   Mendoza Mendoza Erika E   Prida Gisselle G   Freitas Michael A MA   Starita Lea M LM   Parvin Jeffrey D JD  

American journal of human genetics 20220222 4


Pathogenic variants in BRCA1 are associated with a greatly increased risk of hereditary breast and ovarian cancer (HBOC). With the increased availability and affordability of genetic testing, many individuals have been identified with BRCA1 variants of uncertain significance (VUSs), which are individually detected in the population too infrequently to ascertain a clinical risk. Functional assays can be used to experimentally assess the effects of these variants. In this study, we used multiplexe  ...[more]

Similar Datasets

2022-01-31 | GSE188426 | GEO
| PRJNA778773 | ENA
| S-EPMC3906639 | biostudies-literature
| S-EPMC343805 | biostudies-other
| S-EPMC3965556 | biostudies-literature
| S-EPMC133733 | biostudies-literature
| S-EPMC4824085 | biostudies-literature
| S-EPMC85188 | biostudies-literature
| S-EPMC5386867 | biostudies-literature
| S-EPMC3245919 | biostudies-literature